Broncus Technologies, Inc.

Company Summary

Broncus Technologies develops and sells innovative solutions for diagnosing and treating lung diseases. The Company’s LungPoint® system allows physicians to plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its FleXNeedle™ catheter is used to obtain biopsy samples and access to hard-to-reach targets.

Transaction Overview

On 21 May, 2012, PneumRx announced that it has expanded its intellectual property portfolio by acquiring key patents and domain names from Broncus Technologies.

Significance of the Transaction

The acquisition allows PneumRx to further strengthen its intellectual property position with several foundational patents in the emphysema/interventional pulmonology space, block competing technologies and take additional segments of the pulmonary disease market.

Healthios Role

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Mergers & Acquisitions

Broncus Technologies, Inc.

Has sold certain emphysema assets to

The undersigned acted as exclusive advisor to Broncus